• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VASCUTEK LTD; THORAFLEX HYBRID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VASCUTEK LTD; THORAFLEX HYBRID Back to Search Results
Catalog Number THP2426X100J
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/15/2023
Event Type  Injury  
Event Description
Endoleak type 1b, on (b)(6), a ct scan revealed endoleak type 1b or dsine suspected.On (b)(6), an additional tevar was performed distally for placement of a stent-graft (valiant,medtronic).Leakage from the distal portion of the previously implanted thoraflex hybrid was resolved.Subsequently, the procedure was completed successfully.No health damage to the patient.
 
Manufacturer Narrative
Manufacturers narrative: clinical code: 4582 no clinical signs, symptoms or conditions: no health damage to the patient.Impact code: 2199 no health consequences or impact: no health damage to the patient.Medical device code: 3191 appropriate term/code not available: leakage (endoleak type 1).Component code: 4755 part/component/sub-assembly term not applicable.Type of investigation: 4114 device not returned: device remains implanted.3331 analysis of production records: a review of manufacturing and qc records confirmed that there were no issues with the manufacture of the device.4111 communication/interviews: additional information and pre/post op scans was requested.4110 trend analysis: a 5-year review of similar complaints (endo leak type 1) gave an occurrence rate of (b)(4) (complaints v sales).No negative trend in the number of complaints received has been identified.4109 historical data analysis: full batch review performed which showed no issues with product or raw materials.
 
Manufacturer Narrative
Manufacturers narrative: clinical code: 4582 no clinical signs, symptoms or conditions: no health damage to the patient.Impact code: 2199 no health consequences or impact: no health damage to the patient.Medical device code : 3191appropriate term/code not available: leakage (endoleak type 1).Component code: 4755 part/component/sub-assembly term not applicable.Type of investigation: 4114 device not returned: device remains implanted.3331 analysis of production records: a review of manufacturing and qc records confirmed that there were no issues with the manufacture of the device.4111 communication/interviews: additional information and pre/post op scans was requested.4110 trend analysis: a 5-year review of similar complaints (endo leak type 1) gave an occurrence rate of (b)(4) (complaints v sales).No negative trend in the number of complaints received has been identified.4109 historical data analysis: full batch review performed which showed no issues with product or raw materials.Investigation findings: 4247 appropriate term/code not available: site confirmed on 18 oct 23that no further information will be obtained for this event.Investigation conclusion: 4315 cause not established: due to a lack of information or return of the device the root cause of this event could not be determined.Correction to date report sent from 10/01/2023 to 11/01/2023.
 
Event Description
Endoleak type 1b, on september 15, a ct scan revealed endoleak type 1b or dsine suspected.On september 19, an additional tevar was performed distally for placement of a stent-graft (valiant,medtronic).Leakage from the distal portion of the previously implanted thoraflex hybrid was resolved.Subsequently, theprocedure was completed successfully.No health damage to the patient.Tis report is being submitted aa final for mfg.Report # 9612515-2023-00026 to provide event closure information for (b)(4).
 
Event Description
Endoleak type 1b, on (b)(6), a ct scan revealed endoleak type 1b or dsine suspected.On september 19, an additional tevar was performed distally for placement of a stent-graft (valiant,medtronic).Leakage from the distal portion of the previously implanted thoraflex hybrid was resolved.Subsequently, theprocedure was completed successfully.No health damage to the patient.Tis report is being submitted aa final for mfg.Report # 9612515-2023-00026 to provide event closure information for comp 5137.
 
Manufacturer Narrative
Manufacturers narrative clinical code 4582 no clinical signs, symptoms or conditions: no health damage to the patient.Impact code 2199 no health consequences or impact: no health damage to the patient.Medical device code 3191appropriate term/code not available: leakage (endoleak type 1) component code 4755 part/component/sub-assembly term not applicable type of investigation 4114 device not returned: device remains implanted 3331 analysis of production records: a review of manufacturing and qc records confirmed that there were no issues with the manufacture of the device 4111 communication/interviews: additional information and pre/post op scans was requested 4110 trend analysis: a 5-year review of similar complaints (endo leak type 1) gave an occurrence rate of 0.068% (complaints v sales).No negative trend in the number of complaints received has been identified 4109 historical data analysis: full batch review performed which showed no issues with product or raw materials.Investigation findings 4247 appropriate term/code not available: site confirmed on 18 oct 23that no further information will be obtained for this event.Investigation conclusion 4315 cause not established: due to a lack of information or return of the device the root cause of this event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
THORAFLEX HYBRID
Manufacturer (Section D)
VASCUTEK LTD
newmains avenue
inchinnan
glasgow, PA49R R
UK  PA49RR
Manufacturer (Section G)
VASCUTEK LTD
newmains avenue
inchinnan
glasgow, PA49R R
UK   PA49RR
Manufacturer Contact
jason whittle
newmains avenue
inchinnan
glasgow, PA49R-R
UK   PA49RR
MDR Report Key17955554
MDR Text Key325899482
Report Number9612515-2023-00026
Device Sequence Number1
Product Code QSK
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P210006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Remedial Action Repair
Type of Report Initial,Followup,Followup
Report Date 11/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/18/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberTHP2426X100J
Device Lot Number25324185
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/04/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age65 YR
Patient SexMale
-
-